Navigation Links
New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
Date:11/16/2011

ts who have had a prior transient ischemic attack (TIA) or stroke.(3) A 5 mg maintenance dose may be considered for patients who weigh less than 132 lbs.(3) Effient is generally not recommended for use in patients 75 years or older,(3) except in high risk patients (diabetes or prior MI), where its effects appears to be greater and its use may be considered.(3) Patients with prior TIA or stroke should not be treated with Effient.(3)  

About Effient

Daiichi Sankyo Company, Limited (TSE: 4568), and Eli Lilly and Company (NYSE: LLY) co-developed Effient, an oral antiplatelet agent discovered by Daiichi Sankyo and its Japanese research partner, Ube Industries, Ltd. Effient helps keep blood platelets from clumping together and developing a blockage in an artery. Effient is approved by the U.S. Food and Drug Administration for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with ACS who are managed with an artery-opening procedure known as PCI. PCI usually includes the placement of a stent to help keep the artery open.

About Acute Coronary Syndrome

ACS, which includes heart attack and a type of chest pain called unstable angina, affects more than one million people in the United States annually.(4) The annual incidence of new heart attacks is estimated to be approximately 610,000 and about 325,000 people will have a recurrent attack.(4) Each year, approximately 645,000 people with ACS are managed with PCI, which typically includes the implantation of a stent that restores blood flow to blocked arteries in the heart.(5) ACS results in significant illness and death, costing Americans more than $150 billion each year.(5) Nearly 60 percent of the U.S. healthcare costs of ACS are due to re-hospitalization.(5) Strategies to prevent recurrent heart attacks and re-hospitalization are important to improve patien
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Triple Analysis: Leukemia, Cancer Vaccines and Peptides
2. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
3. PRA Early Phase Experts to Speak at Bioanalysis Conference
4. Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
5. New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response
6. Turkey Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2017
7. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
8. Molecular Devices, LLC Introduces SoftMax Pro® 6 Microplate Data Acquisition and Analysis Software With Powerful New Data Analysis and Reporting Features
9. Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
10. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
11. Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... 22, 2014  Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... Munich -based Brainlab to be the ... This agreement applies to the US ENT market; ... and all distribution outside the U.S. The system, ...
(Date:9/22/2014)... 2014  Sutro Biopharma today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Sutro has earned some careful ... as industry partners for what promises to be a ... John Carroll , editor of FierceBiotech .  ...
Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... China , announced today that it,will release its financial results for ... of the market on Monday, August 16, 2010 . The ... at 8:00 a.m. ET to review,the Company,s financial ...
... Advanced Brain Technologies today announced results demonstrating that a modified ... Down syndrome. The results of the study, conducted in Nottingham, United ... of the article scheduled to appear in the journal Music and Medicine(i). ... It ...
Cached Medicine Technology:Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 2Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 3Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 2Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 3
(Date:9/22/2014)... 2014 As concerns about the ... morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) in gynecological surgeries mount, ... the continued use of uterine morcellation by some ... discouraged these procedures. According to The Wall Street ... risks associated with power morcellators are overblown, and ...
(Date:9/22/2014)... CareFlight Air & Mobile Services ... new AS365 N3+ Dauphin, the latest version of Airbus ... is based at Miami Valley Hospital in ... medical transport helicopters. , “We have a lot of ... Vice President, Emergency, Trauma, and CareFlight. “We’ve been operating ...
(Date:9/22/2014)... 2014 PCI (Project Concern International) ... equip women around the world with tools and training ... Women Empowered (WE) Initiative announced at the CGI Annual ... to pool their savings, invest in their own businesses, ... to ending poverty in the world, and through our ...
(Date:9/22/2014)... NY (PRWEB) September 22, 2014 The ... the Department of Surgery at the Icahn School of ... Doctors New York Group for Plastic Surgery gives residents ... access to a team of world-renowned plastic surgeons performing ... C. Andrew Salzberg, MD, who led NYGPS, was named ...
(Date:9/22/2014)... WHO: LiveOps, Inc., the global ... solutions. , WHAT: The 10th annual Customer Response ... for the connected consumer. Constant change in technology ... challenges and opportunities for customer experience executives. The ... practices, network and learn from fellow attendees, speakers ...
Breaking Medicine News(10 mins):Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 3Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 3Health News:LiveOps To Lead Panel Discussion At Customer Response Summit Memphis 2
... UK after a successful bypass surgery in Delhi at a ... tourism.// ,Mavis Childs, 67, waited for more than two ... (NHS). But she opted for India when the operation was ... ,Childs, based in Wombourne, near Wolverhampton, says she traveled ...
... In a startling discovery, researchers have found that more ... several species that are popular pets. // , ... on Nov. 16), revealed that the symptoms like pain ... to the bacteria that thrive on bits of meat ...
... known as Kyolic may decrease the risk of heart ... to UK scientists.// ,Dr. Khalid Rhaman and colleagues ... supplementation of Kyolic brand aged garlic extract inhibits platelet ... blood clots. Clot formation inside healthy blood vessels is ...
... Another plant extract called Forskolin has been found to be ... cells in cultures and mice by up to 90 percent.// ... coleus forskohlii, a native of India that is used as ... plant in the US., ,CML, a malignant cancer of ...
... and Industry magazine says that tropical plants imported from ... and other related illnesses. // ,The Asian tiger ... this species was detected in the Netherlands leading to ... mosquitoes were detected in imported bamboo in a greenhouse ...
... some kinds of live mutated viruses can cure tumors in ... of Glasgow treated a patient with an aggressive //form of ... New Scientist reported. ,A mutation of the herpes virus ... four months to live in 1997. But, eight years later ...
Cached Medicine News:Health News:British Grandmother has timely bypass surgery in India 2Health News:More Lizards, Including Pets, Found Venomous 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: